Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Should You Avoid Platinum Underwriters Holdings, Ltd. (PTP)?

Page 1 of 2

Is it smart to be bullish on Platinum Underwriters Holdings, Ltd. (NYSE:PTP)?

In the financial world, there are plenty of methods investors can use to watch Mr. Market. A pair of the most under-the-radar are hedge fund and insider trading movement. At Insider Monkey, our research analyses have shown that, historically, those who follow the top picks of the best hedge fund managers can outperform the S&P 500 by a healthy amount (see just how much).

Equally as useful, bullish insider trading activity is another way to analyze the stock market universe. Just as you’d expect, there are a number of incentives for an insider to downsize shares of his or her company, but just one, very clear reason why they would buy. Many academic studies have demonstrated the valuable potential of this tactic if investors understand what to do (learn more here).

Thus, let’s analyze the latest info surrounding Platinum Underwriters Holdings, Ltd. (NYSE:PTP).

How have hedgies been trading Platinum Underwriters Holdings, Ltd. (NYSE:PTP)?

In preparation for the third quarter, a total of 11 of the hedge funds we track were bullish in this stock, a change of -21% from the first quarter. With hedgies’ positions undergoing their usual ebb and flow, there exists a select group of key hedge fund managers who were boosting their stakes substantially.

Platinum Underwriters Holdings, Ltd. (NYSE:PTP)According to our 13F database, Citadel Investment Group, managed by Ken Griffin, holds the largest position in Platinum Underwriters Holdings, Ltd. (NYSE:PTP). Citadel Investment Group has a $38.6 million position in the stock, comprising 0.1% of its 13F portfolio. Coming in second is Cliff Asness of AQR Capital Management, with a $20.2 million position; 0.1% of its 13F portfolio is allocated to the stock. Remaining hedgies that hold long positions include Chuck Royce’s Royce & Associates, David Dreman’s Dreman Value Management and John Thiessen’s Vertex One Asset Management.

Because Platinum Underwriters Holdings, Ltd. (NYSE:PTP) has experienced a fall in interest from the smart money’s best and brightest, logic holds that there were a few hedgies that slashed their entire stakes in Q1. Intriguingly, Brian Taylor’s Pine River Capital Management said goodbye to the largest position of the 450+ funds we watch, comprising an estimated $10.7 million in stock. Raymond J. Harbert’s fund, Harbert Management, also dropped its stock, about $7.5 million worth. These bearish behaviors are interesting, as aggregate hedge fund interest fell by 3 funds in Q1.

What do corporate executives and insiders think about Platinum Underwriters Holdings, Ltd. (NYSE:PTP)?

Insider buying is best served when the primary stock in question has seen transactions within the past six months. Over the last half-year time frame, Platinum Underwriters Holdings, Ltd. (NYSE:PTP) has experienced zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

We’ll also review the relationship between both of these indicators in other stocks similar to Platinum Underwriters Holdings, Ltd. (NYSE:PTP). These stocks are Enstar Group Ltd. (NASDAQ:ESGR), Endurance Specialty Holdings Ltd. (NYSE:ENH), MBIA Inc. (NYSE:MBI), Kemper Corporation (NYSE:KMPR), and Radian Group Inc (NYSE:RDN). This group of stocks are the members of the property & casualty insurance industry and their market caps resemble PTP’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!